Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announced data evaluating an...
Genetic Technologies Limited (NASDAQ: GENE) is pleased to
announce a partnership with international race car driver Ms. Pippa Mann to promote BREVAGenplus®,
the Company's first-in-class, clinically validated risk assessment test for sporadic...
Oops! Unable to complete your request. Please refresh your browser.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.
You may also be interested in articles related to GENETIC TECHNOLOGIES (GENE):